GURVINDER HERLIHY: Open Payments
NPI 1033384961 · BLOOMINGDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 15 payments from 9 companies in 2025. Trend: 2023 $1,546 · 2024 $366 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Genentech USA, Inc. | 3 | $53 |
| Amgen Inc. | 2 | $41 |
| ALK-Abello, Inc | 1 | $31 |
| Greer Laboratories, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: DUPIXENT, Xolair, TEZSPIRE, Odactra, ORALAIR, Rhapsido, NUCALA, UBRELVY.
Industry payments across IL — which companies pay providers there.
